Christopher I. Wright's Insider Trades & SAST Disclosures
Christopher I. Wright's most recent trade in Alkermes plc was a trade of 6,104 Ordinary Shares done . Disclosure was reported to the exchange on June 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher I. Wright.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 15,881 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 29 Jun 2024 | 1,465 | 14,416 (0%) | 0% | 24.1 | 35,307 | Ordinary Shares |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2024 | 3,301 | 3,301 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2024 | 3,301 | 10,570 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Christopher I. Wright | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.91 per share. | 08 Jun 2024 | 793 | 9,777 (0%) | 0% | 23.9 | 18,961 | Ordinary Shares |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 355 | 18,128 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 254 | 12,986 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 231 | 11,785 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 129 | 6,602 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 119 | 6,104 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 14 | 728 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 8,699 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Christopher I. Wright | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.88 per share. | 07 Jul 2023 | 1,430 | 7,269 (0%) | 0% | 29.9 | 42,728 | Ordinary Shares |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 12,732 | 12,732 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 5,985 | 5,985 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 3,236 | 6,473 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 3,236 | 3,519 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Christopher I. Wright | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.54 per share. | 08 Jun 2023 | 777 | 2,742 (0%) | 0% | 31.5 | 24,507 | Ordinary Shares |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 373 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 373 | 373 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Christopher I. Wright | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.54 per share. | 08 Jun 2023 | 90 | 283 (0%) | 0% | 31.5 | 2,839 | Ordinary Shares |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 11,554 | 11,554 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,957 | 5,957 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,773 | 17,773 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 9,709 | 9,709 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 714 | 714 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 373 | 373 | - | - | Restricted Stock Unit Award | |
| Cyclerion Therapeutics Inc | Christopher I. Wright | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.99 per share. | 25 Feb 2021 | 2,637 | 42,728 (0%) | 0% | 4.0 | 10,522 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges